The Global market for cardiac safety services was valued at approximately USD 436.6 million in 2019 and is anticipated to generate revenues of approximately USD 953.2 million by the end of 2026, expanding at a CAGR of approximately 11.8 percent between 2020 and 2026.
The report provides forecasts and analyses for the global and regional cardiac safety services markets. The study provides historical data from 2016 to 2019 and revenue projections from 2020 to 2026. (USD Million). The study examines the market drivers and restraints for cardiac safety services, as well as their impact on demand over the forecast period. In addition, the report investigates global and regional market opportunities for cardiac safety services.
In order to provide readers with a thorough understanding of the cardiac safety services market, we have included a competitive landscape and Porter’s Five Forces analysis. The study includes an analysis of market attractiveness, in which all segments are compared based on market size, growth rate, and overall attractiveness.
The report provides a market share analysis of key players in the cardiac safety services market in order to provide a comprehensive overview of the competitive landscape. In addition, the report covers key strategic developments of the market, such as acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major players involved in the global and regional cardiac safety services market.
Global Cardiac Safety Services Market: Type
- Standalone
- Integrated
Global Cardiac Safety Services Market: By Service Type
- ECG/Holter Measurement
- Thorough QT Studies
- Blood Pressure Measurement
- Cardiovascular Imaging
- Other Services
Global Cardiac Safety Services Market: By End User
- Contract Research Organizations (CROs)
- Biopharmaceutical and Pharmaceutical Companies
- Other End Users
Global Cardiac Safety Services Market: By Region
- North America
- The U.S.
- Canada
- Europe
- France
- Germany
- The UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- South Korea
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- South Africa
- GCC
- Rest of the Middle East & Africa
By segmenting the cardiac safety services market based on type, service type, end user, and region, this study provides a comprehensive analysis of the market. All market segments for cardiac safety services have been analysed based on present and future trends, and the market from 2016 to 2026 has been forecasted.
According to the report, the global market for cardiac safety services was worth approximately USD 436.6 million in 2019 and is projected to generate revenue of approximately USD 953.2 million by the end of 2026, expanding at a CAGR of approximately 11.8% between 2020 and 2026.
Based on type, the global market for cardiac safety services is divided into standalone and integrated segments. The global cardiac safety services market is segmented by service type into cardiovascular imaging, blood pressure measurement, thorough QT studies, ECG/Holter measurement, and other services. According to end user, the market is divided into contract research organisations (CROs), biopharmaceutical and pharmaceutical firms, and other end users. North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa comprise the regional segment.
Pharmaceutical Product Development LLC, Biotrial, Certara L.P., Celerion, Inc., ERT, Inc., Laboratory Corporation of America Holdings, Banook Group, Bioclinica (a subsidiary of Cinven), Medpace Holdings, Inc., Ncardia AG, Richmond Pharmacology, PhysioStim, Shanghai Medicilon Inc., SGS S.A., BioTelemetry, Inc., and IQVIA are some major players in the cardiac safety services
Read Our Report:
Infusion Pump Market is growing at a CAGR of around 6.8% between 2020 and 2026
